I know you’ve had many questions about DOC. You don’t really like averaging down. You do think DOC has great potential with some good contracts signed in past few months with good revenue growth through acquisition but it is risky. I’m not risk averse and I have an extensive well-diversified portfolio. I think so too but the stock price keeps dropping like a wet diaper. I’m in with 10,000 shares at an avg price of 1.64. I have time to wait and willing. All things considered…Should I jump in now at .98? Thanks!
Q: This company looks very interesting to me especially recent results. I have a very small position but am considering adding more in a small cap / speculative portfolio. What do you think of the company? Do you think it’s a good buy? Thanks
Q: What do you think of Atmofizer Technologies? It's around 200M market cap and it seems to have some innovative technology in the air filtration space that it's showcasing at the CES in Vegas starting today.
Q: i see that trade desk received an upgrade from jeffries friday a.m.
will this help acuity or is it irrelevant.
the other thing the january bounce from tax loss selling does not seem to be happening.
i get it tech stocks are under the gun and small cap tech even more.
i know its cheap cheap cheap especially when compared to trade desk.
are you sticking with acuity.
dave
Q: This will be an ugly day for Berkeley. Is this a good opportunity gone bad. How do you like it’s future prospects? Would you buy today, being it’s all time low?
Could you please give me your opinion of the stock at current price levels? I have been holding on to it through the decline and am wondering if it should have a place in the risky portion of the portfolio? With the rotation out of growth providing opportunities at now lower valuations, where would you place OSTK in the spectrum?
Regards
Rajiv
Has anything material changed your view of this company? It has smashed through its 52 wk low, and if still a good story then I'll stay put. Do know when it will be profitable?
Q: I am under the impression a company must release any material news asap? If so, is it a fair presumption a release like this means the news isnt material? "Sernova to Announce New Interim Results of its Type 1 Diabetes Clinical Trial During the 40th Annual J.P. Morgan Healthcare Conference"
Q: Looking through past questions, your comments and outlook on PRN are quite positive, yet I don't see much to like about this stock. The company has missed earnings estimates for the past 2 years (all substantial losses), and its revenue seems to be growing (somewhat) but it's been inconsistent, along with several other negative signs (e.g. 27x sales, inherently higher risk of a small company). Could you please explain your reasoning so I can better understand what I'm missing. Thanks.